期刊
MEDICINAL CHEMISTRY RESEARCH
卷 32, 期 2, 页码 271-287出版社
SPRINGER BIRKHAUSER
DOI: 10.1007/s00044-022-03001-x
关键词
Benzoxazepines; 1; 2; 3-Triazoles; Anticancer agents; In vitro bioassay; Docking study
A series of novel 1,2,3-triazole-benzoxazepine hybrid molecules were synthesized and evaluated for their anticancer properties. Three compounds showed excellent anticancer properties with micromolar IC50 values against the oncogenic kinase FLT3.
A series of novel 1,2,3-triazole-benzoxazepine hybrid molecules were synthesized and evaluated for their anticancer properties against four cancer cell lines (Caco-2, PC3, MCF-7, and HL60). Most of the synthesized compounds exhibited moderate to good cytotoxicity against tested cancer cell lines. Three of the prepared compounds, namely, 2, 3, and 4, showed excellent anticancer properties with micromolar IC50 values ranging from 6 to 18 mu M. In silico pharmacophore profiling followed by in-vitro enzyme assays showed 2, 3, and 4 to have micromolar inhibitory IC50 values against the oncogenic kinase FLT3. These compounds represent new inhibitory leads of novel chemotypes against FLT3. [Graphical ]
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据